To report an adverse event or product complaint please call 844-4-SAGERX

♥

View All Selected

Clear All

Funding & Giving

Sage supports people and organizations that come together to create positive, lasting change.

Working together, Sage believes we can achieve our mission to pioneer solutions to help deliver life-changing brain health medicines, so every person can thrive. We offer grants and sponsorships to organizations and initiatives aligned with our mission and strategy.

Grants & Sponsorships

Where possible, Sage seeks to support the work of scientists, researchers, and community-based organizations aligned with our mission with select grants, sponsorships, and other funding opportunities. All funding requests must follow Sage's internal policies and procedures, as well as all applicable laws, regulations, and industry codes. Sage will not support requests from organizations that discriminate on the basis of age, political affiliation, race, national origin, ethnicity, gender, disability, sexual orientation or religious beliefs.

The following information provides more context regarding the types of requests Sage will consider funding and is most likely to accept. Please note that Sage will only consider funding and giving requests made through the request forms linked to this site. While we appreciate each request we receive, Sage cannot support every application for funding. All decisions are final.

Grants

Sage's Medical Educational Areas of Interest

Disease State

Postpartum Depression (PPD)
- Understanding the burden of PPD and the impact of delayed diagnosis and treatment on patient and family outcomes
- Increasing awareness of optimal approaches for the early identification of PPD and opportunities for improved interdisciplinary care of patients with PPD
- Advances in the understanding of the pathophysiology of PPD, including but not limited to the potential role of endogenous neuroactive steroids and GABAergic neurotransmission in the expression of PPD symptoms
- Review of evidence of safety and efficacy of new and emerging pharmacotherapies for PPD

Education for HCPs, including but not limited to the following audiences:

Obstetricians/Gynecologists (OB/GYN), Maternal Fetal Medicine Specialists, OB/GYN Nurse Practitioners (NPs) including Nurse Midwives, and Women’s Health NPs
Reproductive Psychiatrists, Psychiatrists, Psychiatric NPs, Psychiatric Physician Associates/Assistants (PAs)
General primary care providers including, but not limited to Medical Doctors/Doctors of Osteopathic Medicine, NPs and PAs working in family practice
Pharmacists including Psychiatric Pharmacists

Format (to support broad, interactive education)

US-based grant applications
Live education (including symposia at national and regional congresses and profession-specific regional series; in person or virtual) with enduring component as warranted
Digital/online asynchronous enduring education
Digital/online microlearning modules
Print or digital articles

Request For Proposals (RFPs)

Sage supports Request for Proposals (RFPs) for independent medical education to improve patient outcomes in areas of unmet medical need aligned to Sage’s medical and scientific objectives.

There are currently no medical education RFPs. Please check back for updates as Sage may publish RFPs in the future.

Title	Therapeutic Area	Area of Interest	Intended Audience	Geographic Area	Application Due Date
(RFP-MDD.PPD_NP) Title: Issue Date: Request for Proposal Process: View RFP (PDF) APPLY HERE	Brain Health	Major Depressive Disorder & Post-Partum Depression	Psychiatric Nurse Practitioners	U.S.	TBD
(RFP-MDD.PPD-PCP) Title: Issue Date: Request for Proposal Process: View RFP (PDF) APPLY HERE	Brain Health	Major Depressive Disorder & Post-Partum Depression	Primary care providers including physicians, family nurse practitioners, family practice providers, and internal medicine practitioners	U.S.	TBD
(RFP-PPD) Title: Issue Date: Request for Proposal Process: View RFP (PDF) APPLY HERE	Brain Health	Post-Partum Depression	Obstetrician and gynecologist providers including nurse midwives and nurse practitioners	U.S.	TBD
(RFP-MDD) Title: Issue Date: Request for Proposal Process: View RFP (PDF) APPLY HERE	Brain Health	Major Depressive Disorder	Managed Care Professionals	U.S.	TBD

Educational Grant Funding Requirements

Educational grant requests must conform to the following:

Grant requests must be unsolicited and must not provide nor promise any benefit to Sage.
Grant requests for support of educational programs with multiple funding sources are preferred.
Educational programs, activities, or materials that are designed to promote the institution’s or organization’s bona fide patient or educational services must relate to an area of interest to Sage.
Funding amounts must be reasonable for the activities proposed and grant funds must only be used for the expenses described in the grant application and the approval agreement.

Educational grant requests may NOT:

Be payable to an individual healthcare provider (HCP) or physician practice, or companies predominantly owned by a practicing individual HCP or his/her spouse, or the charitable arm thereof.
Request use of funding to support conference travel grants or registration fees for HCPs (other than funding of scholarships to permit medical students, residents, fellows or other HCPs in training to attend carefully selected educational conferences without naming the recipient).
Be for education that is routine and/or a required part of medical training, e.g. textbooks, journal subscriptions, or preparation materials for Board reviews.

Timing / Review Process / Decision for Educational Grants

In 2023, grant submissions will be reviewed on a quarterly basis. Below are timeframes for the quarterly reviews and corresponding submission deadlines:

2023-2024 quarterly submission periods:

Q3 Grants Submission Cycle
2023 Q3 CME Grant submission opening: June 1, 2023
2023 Q3 CME Grant submission deadline: July 1, 2023
2023 Q3 Decision Announcement Date: September 15, 2023

Q4 Grants Submission Cycle
2023 Q4 CME Grant submission opening: September 1, 2023
2023 Q4 CME Grant submission deadline: October 1, 2023
2023 Q4 Decision Announcement Date: November 27, 2023

Funding decisions for grants are made through a formal, centralized grant review and decision-making process.

In all cases, Sage notifies applicants of decisions by email. All applications recieve a fair review, and we encourage organizations to reapply for future programs and initiatives.

Apply Now

If you have any questions, please email grants@sagerx.com.

SPONSORSHIPS

Funding Requirements

Sponsorship requests:

Must clearly identify the benefit offered to Sage.
Must include sponsorship benefits and any amount requested must be reasonable for the activities proposed and consistent with comparable meetings or events.
Must be made available to multiple organizations, and not just to Sage.

Timing / Review Process / Decision

All sponsorship requests will be reviewed on an ongoing basis. Funding decisions for sponsorships are made through a formal, centralized review and decision-making process.

In all cases, Sage notifies applicants of our decision by email. All applications receive a fair review, and we encourage organizations to reapply for future programs and initiatives.

Apply Now

If you have any questions, please email sponsorship@sagerx.com.

Externally Sponsored Research

Sage is committed to supporting research that furthers scientific and clinical understanding of life-altering brain health disorders.

Externally Sponsored Research refers to Investigator Initiated Research (IIR) and Collaborative Research (CR) where the research is sponsored or led by an external, non-Sage, Sponsor-Investigator or Sponsor. For clinical research, the external Sponsor-Investigator or Sponsor is always the regulatory sponsor.

Scientific Areas of Interest

Sage is currently not accepting Externally Sponsored Research proposals. Please check back later for information about Sage's Scientific Areas of Interest.

Investigator Initiated Research (IIR)

IIR is a research grant that is initiated, sponsored, and conducted by a Sponsor-Investigator or Sponsor that is intended to answer an unmet scientific or developmental need. IIR Grant Requests may be submitted to Sage for consideration of funding and/or in-kind drug support. IIR Grant Requests will be accepted only from countries where Sage has an approved product. It does not apply to Sage-sponsored clinical trials or research, Collaborative Research, or to expanded access or compassionate use of Sage products or investigational compounds.

Sage is not currently accepting Externally Sponsored Research proposals. Please check back later for information about IIRs.

IIR grant submissions are reviewed on a quarterly basis. Below are the timeframes for the quarterly reviews and corresponding submission deadlines.

2023-2024 quarterly submission periods:

If you have any questions, please email ESR@sagerx.com.

Collaborative Research (CR)

Collaborative Research refers to studies conducted by an External Sponsor-Investigator or Sponsor in collaboration with Sage Therapeutics (Sage), that are intended to address an unmet scientific, or developmental need, aligned with Sage’s vision and values. Collaborative Research studies are not Sage Sponsored Studies; however, Sage may provide support for these studies beyond funding and/or drug supply, in accordance with the written Collaborative Research Agreement. Collaborative Research study concepts and study designs are collaboratively driven by Sage and the External Sponsor-Investigator or Sponsor.

Sage is not currently accepting Externally Sponsored Research proposals. Please check back later for information about CR.

Sage is currently not accepting Externally Sponsored Research proposals. Please check back later for information about Sage's CR Submission Dates.

If you have any questions, please email ESR@sagerx.com.

Thank you for your interest in Sage Therapeutic’s Investigator Initiated Research program. We are not accepting IIR submissions at this time – please check back at a later date.

If you have any questions, please email grants@sagerx.com.

Report Adverse Event

If you have an adverse event or product complaint to report, please call 844-4-SAGERX

SAGE THERAPEUTICS, ZULRESSO and their respective logos, and SAGE CENTRAL are registered trademarks of Sage Therapeutics, Inc. All other trademarks referenced herein are the property of their respective owners.

MRC-None-00015 09/23